Paracetamol Discontinuation in the Elderly After Long-term Consumption
Paracetamol Discontinuation in the Elderly After Long-term Consumption
To investigate if long-term treatment of paracetamol can be discontinued without no worsening on pain, health-related quality-of-life and level of function compared to continuing paracetamol treatment in patients aged 65 years or more.
Aim: To investigate if long-term treatment of paracetamol can be discontinued without worsening on pain, health-related quality-of-life and level of function compared to continuing paracetamol treatment in patients aged 65 years or more.
Trial design: Patients are randomized to either arm 1: standard care (paracetamol continuation) or arm 2: experimental treatment (placebo).
The investigation is double-blinded.
Patients are screened and recruited from Department of respiratory medicine at Copenhagen University Hospital Bispebjerg. Patients with a daily consumption of 3 grams or more of prescribed paracetamol and who comply with the other eligibility criteria will be invited to participate in the trial and asked for written, informed consent. If given we collect data regarding the patient's medications, any medication changes during the intervention and followup, frailty (FRAIL Scale), self-reported history of falls, recent admissions, self-reported health-related quality of life (EQ-5D-5L), level of function tested by hand grib strength and sitting-rising test, and death.
Data is collected at baseline and after 2 weeks when ending treatment intervention, and a 26 week follow-up.
Inclusion Criteria:
Exclusion Criteria:
Charlotte.Vermehren@regionh.dk+45 3863 5209
lykke.ida.kaas.oldenburg@regionh.dk+45 38635807